References
- von Scheidt W, Welz A, Pauschinger M, Fischlein T, Schächinger V,
Treede H, et al. Interdisciplinary consensus on indications for
transfemoral transcatheter aortic valve implantation (TF-TAVI): Joint
Consensus Document of the Arbeitsgemeinschaft Leitende Kardiologische
Krankenhausärzte e.V. (ALKK) and cooperating Cardiac Surgery
Departments. Clin Res Cardiol. 2020;109(1):1-12.
- Levett JY, Windle SB, Filion KB, Brunetti VC, Eisenberg MJ.
Meta-Analysis of Transcatheter Versus Surgical Aortic Valve
Replacement in Low Surgical Risk Patients. Am J Cardiol. 2020;28:
S0002-9149(20)30058-8.
- Vipparthy SC, Ravi V, Avula S, Kambhatla S, Mahmood M, Kabour A et al.
Meta-Analysis of Transcatheter Aortic Valve Implantation Versus
Surgical Aortic Valve Replacement in Patients With Low Surgical Risk.
Am J Cardiol. 2020;125(3):459-468.
- Kolte D, Vlahakes GJ, Palacios IF, Sakhuja R, Passeri JJ, Inglessis I,
et al. Transcatheter Versus Surgical Aortic Valve Replacement in
Low-Risk Patients. J Am Coll Cardiol. 2019;74(12):1532-1540.
- D’Auria F, Casado AP, Myat A, Lorusso R, Hildick-Smith D. Long-Term
Survival and Outcomes According to VARC-2 Criteria for Subclavian,
Direct Aortic, Femoral, and Apical Implantation: An 8-Year United
Kingdom TAVI Surgical Experience. Surg Technol Int. 2020;37:
sti37/1327. Online ahead of print.
- Overtchouk P, Modine T. Alternate Access for TAVI: Stay Clear of the
Chest. Interv Cardiol. 2018;13(3):145-15.
- Ruge H, Lange R, Bleiziffer S, Hutter A, Mazzitelli D, Will A, et al.
First successful aortic valve implantation with the CoreValve
ReValvingTM system via right subclavian artery access: a case report,
Heart Surg Forum 11 (2008) E323–E324.
- Myat A, Papachristofi O, Trivedi U, Bapat V, Young C, de Belder A, et
al. Transcatheter aortic valve implantation via surgical subclavian
versus direct aortic access: A United Kingdom analysis. Int J Cardiol.
2020;308:67-72.
- Takagi H, Hari Y, Nakashima K, Kuno T, Ando T, ALICE (All-Literature
Investigation of Cardiovascular Evidence) Group. Comparison of early
and midterm outcomes after trans subclavian/axillary versus
transfemoral, transapical, or transaortic transcatheter aortic valve
implantation. Heart Lung. 2019;48(6):519-529.
- Rahhab Z, El Faquir N, Tchetche D, Delgado V, Kodali S, Mara Vollema
E, et al. Expanding the indications for transcatheter aortic valve
implantation. Nat Rev Cardiol. 2020;17(2):75-84.